Riskpilot← Back to searchSign inGet full accessBetulaceae Pharmaceuticals AB
ABIn liquidationOrg 5590472923UmeåManufacture of pharmaceutical preparations · NACE 2120Est. 20160 employees
Revenue 2025
—
EBITDA margin
—
-697% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
SEK -16K
-694% vs 2024
| Revenue | — | — |
| EBITDA | SEK -16K | -697% |
| Net profit | SEK -16K | -694% |
| Total assets | SEK 12K | -56% |
| Equity | SEK 12K | -56% |
| Employees | 0 | — |
Legal name
Betulaceae Pharmaceuticals AB
Org number
5590472923
Legal form
Aktiebolag
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
15 januari 2016
Share capital
SEK 55 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn Firman tecknas var för sig av externa firmatecknarna
Company purpose
Bolaget skall arbeta med läkemedelsutveckling samt därmed förenlig verksamhet.
Address
Umeå
Email
info@heinestams.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | −4 | −3 | −4 | −2 | −16 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | −4 | −3 | −4 | −2 | −16 |
| Net financials | — | — | — | — | 0 |
| Profit before tax | −4 | −3 | −4 | −2 | −16 |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | −4 | −3 | −4 | −2 | −16 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 31 | 30 | 29 | 28 | 12 |
| Equity | 28 | 28 | 28 | 28 | 12 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 3 | 2 | 1 | 0 | — |
| Total debt | 3 | 2 | 1 | — | — |
EBITDA margin
-1595000.0%
This company
15.8%
Market median
-10095037% vs market
20212025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20212025
Return on equity
-130.3%
This company
18.4%
Market median
-808% vs market
20212025
Net profit margin
-1588400.0%
This company
8.1%
Market median
-19609977% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
SM External Signatory | External Signatory | 2025 |
SM External Signatory | External Signatory | 2025 |
EF External Signatory | External Signatory | 2025 |
MV Liquidator | Liquidator | 2025 |
AB External Signatory | External Signatory | 2025 |
AE External Signatory | External Signatory | 2025 |
| Former (1) | ||
RJ Chief Executive Officer | Chief Executive Officer | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
| Deputy Board Member | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
| Chairman | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Betulaceae Pharmaceuticals AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rolf Jonas Andreas Nilsson | Chief Executive Officer | 0 companies |
| Sofie Margareta Lundberg | External Signatory | 0 companies |
| Susanne Margareta Fransson | External Signatory | 0 companies |
| Emma Frida Ramona Melander Vängbo | External Signatory | 0 companies |
| Mona Veronica Vesterberg | Liquidator | 0 companies |
| Anna Birgitta Emanuelsson | External Signatory | 0 companies |
| Anna Elisabeth Adolfsson | External Signatory | 0 companies |
| James Fredrick Anderson | Deputy Board Member | 0 companies |
| Stefan Kristoffer Nilsson | Board of Directors | 0 companies |
| Konrad Forster Koehler | Board of Directors | 0 companies |
| Lars Ole Öhman | Chairman | 0 companies |